US domestic steroids - no customs
Fast USA delivery
Buy original steroids online USA
Ripped Look Endurance Cycle

Ripped Look Endurance Cycle

  • $575.00



**3 x Ultima-Drostan P 100 - Ultima Pharmaceuticals** [10 ml x 100 mg/ml]
**16 x Ultima-Oxa 10 - Ultima Pharmaceuticals** [50 pills x 10 mg]
**2 x Ultima-Clen-Salbuto - Ultima Pharmaceuticals** [50 pills x 2 mg]
**1 x Ultima-Nolva - Ultima Pharmaceuticals** [50 pills x 20 mg]

MANUFACTURER Ultima Pharmaceuticals - Cycles
WAREHOUSE International Warehouse 3
SUBSTANCE Drostanolone Propionate, Oxandrolone, Tamoxifen Citrate, Salbutamol

Brand: Ultima Pharmaceuticals

Unleash Your Potential with the 14-Week Ripped Look Endurance Cycle

Transform your physique with this expertly crafted cycle from Ultima Pharmaceuticals, designed specifically for achieving that coveted ripped look in bodybuilding. This unique stack combines the synergistic powers of Masteron and Anavar, enhancing their individual effects for optimal muscle definition and cutting. Although it may be less familiar in Europe, this combination is a favorite in the U.S., especially among fitness enthusiasts and entertainers.

One of the standout features of this steroid stack is its safety profile. With no aromatization or prolactin activity, users can say goodbye to concerns about water retention, acne, high blood pressure, gynecomastia, or any androgenic side effects. Perfect for pre-summer prep or getting camera-ready, this cycle is not tailored for bulking; however, athletes can still expect to gain an impressive 5 kg of lean mass thanks to Anavar's potent anabolic properties.

- **Ultima-Drostan P 100:** 200 mg per week, divided into 3 doses - **Ultima-Oxa 10:** 40-80 mg per day - **Post Cycle Therapy (PCT):** Half the standard dose of Ultima-Nolva in conjunction with Ultima-Clen-Salbuto PCT

Dosage:

While we share our insights based on experience, please remember that we are not professionals. Always consult with a healthcare provider for personalized advice.

OSGear disclaims any responsibility for potential issues arising from use or results related to this cycle.